Navigation Links
Bristol-Myers Squibb Invites Public to Listen to Webcast of 2008 Annual Meeting
Date:4/30/2008

NEW YORK, April 30 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) invites investors and the general public to listen to a webcast of its annual meeting with stockholders at 10 a.m. ET on Tuesday, May 6, 2008. In addition to the stockholder and board items to be transacted, senior executives will review the status of the company's business.

For information on how to listen to the webcast, please visit the Investor Relations page of the Bristol-Myers Squibb website at http://www.bms.com/ir.

Bristol-Myers Squibb is a global biopharmaceutical and related health care products company whose mission is to extend and enhance human life.


'/>"/>
SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Bristol-Myers Squibb Issues $1.6 Billion of Senior Notes
2. Strong Double-Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol-Myers Squibb Company
3. Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer
4. BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING PCSK9 AS DEVELOPMENT CANDIDATE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE
5. Repligen Announces Settlement with Bristol-Myers Squibb in Orencia(R) Lawsuit
6. Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer
7. Bristol-Myers Squibb Announces Dividend
8. Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board
9. Bristol-Myers Squibb to Announce Results for the Fourth Quarter and Full Year of 2007 on January 31
10. Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb
11. EDS Awarded $715 Million Contract for Bristol-Myers Squibb Information Services

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...employment grew by 29,000 jobs in October, and th...owth during the U.S. recession. However, clinics a...th systems are coming closer to having to actually...tors. , (Vocus) November ...ng in October despite the shedding of jobs in most...
(Date:11/24/2009)...re-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiop...alizingnovelpainmanagementtherapies,announcedtoday...er,isscheduledtopresentatthe21stAnnualPiperJaffray...NewYorkPalaceHotelinNewYork,NewYork. ,, Mr.DiTo...eavailabletorespondtoquestionsduringthepresentatio...
(Date:11/24/2009)...tly approved the Promega PowerPlex 16 HS System fo...ng DNA records for the National DNA Index System. ... -- The FBI recently approved the Promega PowerPl...icipating in, or generating DNA records for, the N...ntains more than seven million profiles and has as...
(Date:11/24/2009)...rstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglo...edthatithassubmittedaMAAtotheEuropeanMedicinesAgen...enttherapyindevelopment,forthetreatmentofType1Gauc...elaglucerasealfathathasbeensubmitted,withprevious,...donaglobalsupplyshortageofthecurrentlyapprovedandm...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...amaze you? It would be hard not to be impressed. A...n just a few years ago are now a part of routine c...amazed again and often. , , In a Wisconsin Tech...e of engineering in health science and technology ...ts in both technology and Wisconsin,s strategy to ...
... southeast Wisconsin received a boost late last we...esearch capital. , ,The Legislature,s Joint Commit...e Biomedical Technology Alliance, an organization ...southeast Wisconsin. The funding, proposed by Sen...ate legislature to be approved with the final budg...
...Inc. said it has raised $1.4 million in a venture...mpany, now about a year old, is developing Univers... and using hydrogen fuel in car engines. Instead o...volves generating it from water and sugars inside ...cal reaction. , ,The firm said Advantage Capital P...
Other Biology Technology:Science, technology and health care evolve 2Biotech Alliance pushes ahead in SE Wisconsin with likely state funding 2Biotech Alliance pushes ahead in SE Wisconsin with likely state funding 3
(Date:11/25/2009)... don,t have easy lives. In addition to mammalian i...ural enemies called bacteriophages, viruses that k... Still, bacteria and another class of microorgani...vironments such as deep-sea volcanic vents) manage... built-in defense system that helps protect them f...
(Date:11/25/2009)...Head of the Cell Death Research Laboratory in the ...een awarded the prestigious Johnson & Johnson Focu...ause of brain cell damage in Parkinson,s disease. ...s in support of innovation and excellence in scien...d earlier this month at an event at the Hyatt Rege...
(Date:11/25/2009)...lifetime, the heart pumps some 250 million liters ..., the muscle fibers of the heart have to be extrem...gang Rottbauer, vice chair of the Department of Me...rman: Prof. Dr. H. A. Katus), has discovered a pro...smallest muscular unit, the sarcomere. In cooperat...
Breaking Biology News(10 mins):Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2New genetic cause of cardiac failure discovered 2The real world of a forensic scientist 10247 1The real world of a forensic scientist 10247 2APWU Health Plan Announces New Benefits and Premiums for 2010 58795 1CardioGenics Holdings Inc Engages Gilford Securities As Investment Banker 14339 1CardioGenics Holdings Inc Engages Gilford Securities As Investment Banker 14339 2
...he Standard Scrapie Cell Assay, measures prion inf... rapid way, producing results in less than two wee...allows researchers to quickly distinguish between ...g the new assays, the scientists were able to show...ifferent responses to four different strains of th...
... have proven that by taking a short stretch of DNA...ng antibiotic they can switch off antibiotic resis...ny PBL, the scientists have launched a spin-out co...hnology. , The DNA sequence acts as a decoy, disr...id Dr Michael McArthur from JIC. , We are puttin...
...gsgemeinschaft (DFG, German Research Foundation) w...es, which will receive a total of 74.4 million eur... a lump sum of 20 percent to cover indirect costs ...search Centres (SFBs) will address a range of topi...ibution of oxygen in tropical oceans, and nanoscop...
Other Biology News:Scripps scientists develop new tests that identify lethal prion strains quickly and accurately 2Decoy makes sitting duck of superbugs 2DFG to establish 10 new collaborative research centers 2DFG to establish 10 new collaborative research centers 3DFG to establish 10 new collaborative research centers 4DFG to establish 10 new collaborative research centers 5
Anti-Taste Receptor 2 (TR2) Polyclonal Antibody, Unconjugated from CHEMICON
Anti-Latanoprost (EIA Antiserum) Antibody, Unconjugated from Cayman Chemical
Anti-SEK1 / MKK4, phospho (Thr261) Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-BACE/Asp2 (CT) Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Biology Products: